Advertisement
Questions remain following late mortality signal from a retrospective cohort study
TAVR explant demands multidisciplinary expertise
Judicious application yields a 99.7% repair rate and 0.04% mortality
Limited data and experience will translate to a cautious rollout
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic series supports re-repair as a favored option regardless of failure timing
Large retrospective study supports its addition to BAV repair toolbox at expert centers
Provides option for patients previously deemed anatomically unsuitable
A call for surgical guidelines to adopt sex-specific thresholds of LV size and function
While mortality was unaffected, later surgery was associated with more reoperations
Many young patients can avoid lifelong anticoagulation with a valve-sparing approach
Advertisement
Advertisement